A considered purchase deserves access to the literature. These are the studies referenced by Echelon, with their methods, protocol differences, and limitations kept in view.
Echelon hyperbaric chambers for the home, studio, and private clinic. Built to order. Configuration and documentation reviewed before production. Lifetime support. Exact pricing in writing after a consult. Echelon builds the environment and makes no claims about outcomes.
BEFORE THE PAPERS
Pressure is only part of the picture.
Research protocols differ in oxygen concentration, pressure, duration, participant health, and clinical supervision. Findings from a study do not establish the performance of an Echelon chamber.
Each chamber pressurizes air. Oxygen is supplied separately through a headset or mask: 93% with 5 or 10 L/min configurations for portables; 93% ±3% at 10 L/min for rigid chambers. Pressure depends on the model. Quietus, Solace, and Atlas offer 1.3 or 1.5 ATA configurations; Meridian lists 1.3 or 1.4 ATA; Vespers lists 1.5 ATA; Cirrus and Nimbus list 2.0 ATA. Cirrus is not UHMS-protocol hyperbaric oxygen therapy. Echelon builds the environment and makes no claims about outcomes.
The publications and resources below discuss clinical-use topics: selected diabetic and non-healing wounds, decompression illness, carbon monoxide poisoning, radiation injury, sudden sensorineural hearing loss, and central retinal artery occlusion. These refer to clinical assessment and treatment, and are not indications for using an Echelon chamber at home.
THE READING ROOM
Seven perspectives. The original sources.
Cellular aging
Hachmo et al. · Aging · 2020
A telomere-length trial at clinical pressure
Examines changes in blood-cell markers in older adults. A small prospective study of biological markers does not establish longer life or a benefit from a particular consumer chamber.
Prospective trial2 ATA · 100% oxygen · 60 sessions
Investigates cognitive performance and brain blood flow under a defined clinical protocol. Results should be read in the context of that population and treatment setting.
A post-concussion trial using 100% oxygen at 1.5 ATA
Examines patients with persistent post-concussion symptoms. Sharing a pressure rating with a chamber does not establish an equivalent oxygen exposure or clinical outcome.
Randomized prospective trial1.5 ATA · 100% oxygen · 40 sessions
Studies symptoms and brain measurements in a selected veteran population. This clinical research is not a recommendation to self-treat PTSD with a chamber.
Randomized controlled trial2 ATA · 100% oxygen · 60 sessions
Short-term diabetic wound-healing findings did not establish a lasting benefit at one year. The review also highlights limitations in the available trials.
Marcinkowska et al. · Neuropsychology Review · online 2021
A systematic review of cognitive outcomes
Reports mixed findings across neurological conditions and calls for stronger, more consistent assessment. The broader evidence matters as much as an individual promising study.
Systematic review · 42 studiesMultiple clinical populations and protocols
This material describes published research, not the performance of Echelon chambers. Echelon builds the environment and makes no claims about outcomes. Consult a qualified healthcare provider before beginning any new practice.
Warranty applies with proper use. Parts and service after warranty are billed at standard rates. Commercial warranty terms are confirmed with your order. Warranty & support details